Possible treatments include enzyme replacement therapy, gene therapy, substrate deprivations, hematopoietic stem-cell transplantation and cord blood transfer. To even hope that pharmaceutical companies will conduct clinical drug trials, they'll first need the results of at least one natural history study (progression of the illness).